Kymera Therapeutics, Inc. Annual Return On Assets in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Kymera Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2023.
  • Kymera Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -20.3 %, a 28.9% increase year-over-year.
  • Kymera Therapeutics, Inc. annual Return On Assets for 2023 was -25.3 %, a 4.89% increase from 2022.
  • Kymera Therapeutics, Inc. annual Return On Assets for 2022 was -26.6 %, a 42.5% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -25.3 +1.3 +4.89% Jan 1, 2023 Dec 31, 2023
2022 -26.6 -7.93 -42.5% Jan 1, 2022 Dec 31, 2022
2021 -18.7 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.